Physiological and pathophysiological functions of cell cycle proteins in post-mitotic neurons: implications for Alzheimer’s disease
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
Alzheimer's disease (AD) is the most prevalent neurodegenerative disorder for which no effective treatment is available. Increased insight into the disease mechanism in early stages of pathology is required for the development of a successful therapy. Over the years, numerous studies have shown that cell cycle proteins are expressed in neurons of AD patients. Traditionally, neurons are considered to be post-mitotic, which means that they permanently retract from the cell cycle. The expression of cell cycle proteins in adult neurons of AD patients has therefore been suggested to promote or even instigate pathomechanisms underlying AD. Interestingly, expression of cell cycle proteins is detected in post-mitotic neurons of healthy controls as well, albeit to a lesser extent than in AD patients. This indicates that cell cycle proteins may serve important physiological functions in differentiated neurons. Here, we provide an overview of studies that support a role of cell cycle proteins in DNA repair and neuroplasticity in post-mitotic neurons. Aberrant control of these processes could, in turn, contribute to cell cycle-mediated neurodegeneration. The balance between regenerative and degenerative effects of cell cycle proteins in post-mitotic neurons might change throughout the different stages of AD. In the early stages of AD pathology, cell cycle protein expression may primarily occur to aid in the repair of sublethal double-strand breaks in DNA. With the accumulation of pathology, cell cycle-mediated neuroplasticity and neurodegeneration may become more predominant. Understanding the physiological and pathophysiological role of cell cycle proteins in AD could give us more insight into the neurodegenerative process in AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Cahoy, J. D., Emery, B., Kaushal, A., Foo, L. C., Zamanian, J. L., Christopherson, K. S., Xing, Y., Lubischer, J. L., Krieg, P. A., Krupenko, S. A., et al. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4178-07.2008 · Cited by 3,129 · cited 1×
“Bioinformatics tools are available to estimate the relative role of cell population using databases of transcripts enriched in astrocytes, neurons, and oligodendrocytes [16, 33].”
MethodAmyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 1×
“The widely accepted, but not undisputed, amyloid cascade hypothesis, proposes that Aβ drives neuritic tau pathology, being an important secondary phenomenon that is closely correlated with the syndrome of dementia [34, 85].”
BackgroundChk2/hCds1 functions as a DNA damage checkpoint in G1by stabilizing p53
Chehab, N. H., Malikzay, A., Appel, M., & Halazonetis, T. D. (2000) · Genes & Development · doi:10.1101/gad.14.3.278 · Cited by 805
Ectopic Cell Cycle Proteins Predict the Sites of Neuronal Cell Death in Alzheimer’s Disease Brain
Busser, J., Geldmacher, D. S., & Herrup, K. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-08-02801.1998 · Cited by 543 · cited 5×
“Second, cell cycle proteins characteristic of G2 phase and M phase have been reported in control cases [12, 15, 20, 65, 98], early AD cases [72, 105] and neurons without apparent pathology [15, 20, 71].”
BackgroundInfluentialCell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
Andorfer, C., Acker, C. M., Kress, Y., Hof, P. R., Duff, K., & Davies, P. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.4637-04.2005 · Cited by 511 · cited 2×
“Over the years, other experimental studies [57, 80], correlative evidence from post-mortem studies (Table 1), and the fact that cell cycle reactivation often accompanies Aβ-, and taumediated cell death have been supportive of this phenomenon [1, 22, 32, 43, 47].”
BackgroundSuberbielle, E., Sanchez, P. E., Kravitz, A. V., Wang, X., Ho, K., Eilertson, K., Devidze, N., Kreitzer, A. C., & Mucke, L. (2013) · Nature Neuroscience · doi:10.1038/nn.3356 · Cited by 487 · cited 2×
“Another potent candidate in AD that could partly be responsible for the occurrence of DSBs is Aβ [94].”
BackgroundNeuronal cell death is preceded by cell cycle events at all stages of Alzheimer’s disease
Yang, Y., Mufson, E. J., & Herrup, K. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-07-02557.2003 · Cited by 483 · cited 9×
“Second, cell cycle proteins characteristic of G2 phase and M phase have been reported in control cases [12, 15, 20, 65, 98], early AD cases [72, 105] and neurons without apparent pathology [15, 20, 71].”
BackgroundInfluentialZhu, X., Rottkamp, C. A., Boux, H., Takeda, A., Perry, G., & Smith, M. A. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.10.880 · Cited by 378 · cited 4×
“Even though cell cycle proteins are often found to colocalize with NFTs, they are also found in neurons without the presence of neurofibrillary pathology.”
BackgroundInfluentialOxidative stress mediates tau-induced neurodegeneration in Drosophila
Dias-Santagata, D., Fulga, T. A., Duttaroy, A., & Feany, M. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28769 · Cited by 318
TOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model
Khurana, V., Lu, Y., Steinhilb, M. L., Oldham, S., Shulman, J. M., & Feany, M. B. (2006) · Current Biology · doi:10.1016/j.cub.2005.12.042 · Cited by 266 · cited 2×
“Over the years, other experimental studies [57, 80], correlative evidence from post-mortem studies (Table 1), and the fact that cell cycle reactivation often accompanies Aβ-, and taumediated cell death have been supportive of this phenomenon [1, 22, 32, 43, 47].”
BackgroundIncreased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment
Wang, J., Markesbery, W. R., & Lovell, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03615.x · Cited by 260 · cited 1×
“Indeed, oxidative DNA damage increases with age, but appears to be even further augmented in MCI patients [99].”
BackgroundExpression of the cyclin-dependent kinase inhibitor p16 in Alzheimerʼs disease
Lars Rödel, T. A., Gärtner, U., & Holzer, M. (1996) · NeuroReport · doi:10.1097/00001756-199611250-00050 · Cited by 250
Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease
Arendt, T., Holzer, M., & Gärtner, U. (1998) · Journal of Neural Transmission · doi:10.1007/s007020050104 · Cited by 137
Frank, C. L., & Tsai, L.-H. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.029 · Cited by 118
Specific Glial Functions Contribute to Schizophrenia Susceptibility
Goudriaan, A., de Leeuw, C., Ripke, S., Hultman, C. M., Sklar, P., Sullivan, P. F., Smit, A. B., Posthuma, D., & Verheijen, M. H. G. (2014) · Schizophrenia Bulletin · doi:10.1093/schbul/sbt109 · Cited by 114
The DNA Replication Stress Hypothesis of Alzheimer’s Disease
Yurov, Y. B., Vorsanova, S. G., & Iourov, I. Y. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/625690 · Cited by 110 · cited 1×
“The underlying mechanism responsible for apoptosis in S phase requires further study, but has been suggested to be due to replicative stress [108].”
BackgroundSilva, A. R. T., Santos, A. C. F., Farfel, J. M., Grinberg, L. T., Ferretti, R. E. L., Campos, A. H. J. F. M., Cunha, I. W., Begnami, M. D., Rocha, R. M., Carraro, D. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099897 · Cited by 99 · cited 1×
“We next put forward that with disease progression, the building up of oxidative stress, genotoxic insults and deterioration of DNA repair mechanisms lead to the accumulation of DSB lesions, which have been found to be increased in AD patients [20, 88], eventually to an extent that is no longer repairable.”
BackgroundCdk5 suppresses the neuronal cell cycle by disrupting the E2F1-DP1 complex
Zhang, J., Li, H., Yabut, O., Fitzpatrick, H., D'Arcangelo, G., & Herrup, K. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.5628-09.2010 · Cited by 96 · cited 1×
“Unlike other CDKs, who are generally activated by a cyclin protein, CDK5 is catalytically activated by p35/ p39 or the more stable fragment p25 and exerts inhibitory control over the cell cycle [110].”
BackgroundHoozemans, J. J., van Haastert, E. S., Veerhuis, R., Arendt, T., Scheper, W., Eikelenboom, P., & Rozemuller, A. J. (2005) · Journal of Neuroinflammation · doi:10.1186/1742-2094-2-27 · Cited by 52 · cited 2×
“Whereas in early Braak stages the temporal cortex is almost devoid of neurofibrillary changes, increased presence of G1 phase markers is observed in this area of the brain [37, 38].”
Self-citationMajd, S., Zarifkar, A., Rastegar, K., & Takhshid, M. A. (2008) · Brain Research · doi:10.1016/j.brainres.2008.04.050 · Cited by 51 · cited 2×
“1 3 Several experimental studies have shown that Aβ and tau can be mitogenic [1, 10, 22, 30, 32, 43, 47, 63, 86, 97], and that Aβ and tau-induced cell death is often mediated by cell cycle activation [1, 22, 32, 43, 47].”
BackgroundHernández‐Ortega, K., Ferrera, P., & Arias, C. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21301 · Cited by 35 · cited 2×
“Lesions in the entorhinal cortex were found to induce cell cycle protein expression (cyclin D1, cyclin B and ERK1/2) in the dentate gyrus of the hippocampus [35], and vice versa (cyclin D1, CDK6, PCNA, CDK2, cyclin B, CDK5 and p25/35) [36].”
Background
Cited by
Systematic Review of miRNA as Biomarkers in Alzheimer’s Disease
Swarbrick, S., Wragg, N., Ghosh, S., & Stolzing, A. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-1500-y · Cited by 350
Li, P., Marshall, L., Oh, G., Jakubowski, J. L., Groot, D., He, Y., Wang, T., Petronis, A., & Labrie, V. (2019) · Nature Communications · doi:10.1038/s41467-019-10101-7 · Cited by 234
Wei, Z., Chen, X.-C., Song, Y., Pan, X.-D., Dai, X.-M., Zhang, J., Cui, X.-L., Wu, X.-L., & Zhu, Y.-G. (2016) · Chinese Medical Journal · doi:10.4103/0366-6999.186646 · Cited by 89
“the abnormality in the expression of cell cycle‐related genes.[14] For example, transformation‐related protein”
BackgroundWelch, G. M., Boix, C. A., Schmauch, E., Davila-Velderrain, J., Victor, M. B., Dileep, V., Bozzelli, P. L., Su, Q., Cheng, J. D., Lee, A., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo4662 · Cited by 84
“Induction of DNA DSBs is sufficient to elicit immune pathway signaling in neuron primary culture. a. Top: Representative images of NeuN and γH2AX immunostaining in ETP and vehicle-treated primary cultures. γH2AX immunoreactivity is quantified for each condition.”
BackgroundInfluentialConnecting Malfunctioning Glial Cells and Brain Degenerative Disorders
Kaminsky, N., Bihari, O., Kanner, S., & Barzilai, A. (2016) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2016.04.003 · Cited by 38
Metadata
- Authors
- van Leeuwen, L. A. G., & Hoozemans, J. J. M.
- Venue
- Acta Neuropathologica
- Published
- 2015-01-25
- Volume
- 129
- Issue
- 4
- Pages
- 511-525
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- OpenAlex
- W2068938464
- Cited by
- 59
- References
- 22
- FWCI
- 2.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.